This inventor holds 8 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 7 EPO patents. Top assignee: Geistlich Pharma Ag. Active years: 2014-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Emmenbruecke, CH (2014 - 2015)
- Eich, CH (2018)
- Reinach, CH (2020 - 2022)
Company Filing History:
Years Active: 2014-2022
Title: Michael Alexander Bufler: Innovator in Bone Substitute Materials
Introduction
Michael Alexander Bufler is a prominent inventor based in Emmenbruecke, Switzerland. He has made significant contributions to the field of biomedical materials, particularly in the development of innovative bone substitute materials. With a total of eight patents to his name, Bufler's work is at the forefront of enhancing bone regeneration and repair.
Latest Patents
Bufler's latest patents include a collagen matrix or granulate blend of bone substitute material. This invention involves a collagen matrix granulate blend that incorporates particles of a biphasic calcium phosphate/hydroxyapatite (CAP/HAP) bone substitute material. The process for making and using this blend includes a sintered CAP core, which is covered by a closed epitactically grown layer of nanocrystalline HAP. This layer is designed to mimic the size and morphology of human bone mineral, enhancing its compatibility and effectiveness in medical applications. Another notable patent focuses on a biphasic calcium phosphate/hydroxyapatite bone substitute material that promotes bone formation and regeneration through its unique structural properties.
Career Highlights
Michael Alexander Bufler is currently associated with Geistlich Pharma AG, a company renowned for its advancements in regenerative medicine. His work at Geistlich Pharma AG has allowed him to push the boundaries of what is possible in bone substitute technology. His innovative approaches have garnered attention in the medical community, leading to advancements in treatment options for patients requiring bone repair.
Collaborations
Bufler has collaborated with notable colleagues such as Claudio Zihlmann and Cornel Imhof. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the development of innovative solutions in the field of bone substitutes.
Conclusion
Michael Alexander Bufler's contributions to the field of bone substitute materials are significant and impactful. His innovative patents and collaborations reflect his commitment to advancing medical technology and improving patient outcomes. His work continues to inspire future developments in regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile